Deltagen Inc.
DGEN · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2010 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $85 | $95 | $3,530 |
| + Debt | $25 | $0 | $100 | $0 |
| Enterprise Value | $25 | -$85 | $5 | -$3,530 |
| Revenue | $263 | $1,022 | $1,054 | $1,987 |
| % Growth | -74.3% | -3% | -47% | – |
| Gross Profit | $77 | $660 | $0 | $0 |
| % Margin | 29.3% | 64.6% | 0% | 0% |
| EBITDA | $77 | -$4,418 | -$990 | -$673 |
| % Margin | 29.3% | -432.3% | -93.9% | -33.9% |
| Net Income | $76 | -$4,418 | -$1,165 | -$685 |
| % Margin | 28.9% | -432.3% | -110.5% | -34.5% |
| EPS Diluted | 0.002 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | $90 | -$665 | -$2,175 |
| Capital Expenditures | – | -$90 | $0 | $0 |
| Free Cash Flow | – | $0 | -$665 | -$2,175 |